Science
Mechanism of Action
As a cellular signal molecule, S-Mussel Oligopeptide-1 precisely binds to specific epidermal growth factor receptors (EGFR) on the surface of skin cells. This binding initiates intricate intracellular pathways, accelerating the production of new skin cells and stimulating the synthesis of crucial structural proteins such as collagen and elastin. This action drives skin regeneration, enhances skin barrier function, and boosts the production of extracellular matrix components like hyaluronic acid, leading to improvements in skin firmness, elasticity, and long-term hydration.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Clinical trials utilizing sh-Oligopeptide-1 formulations have demonstrated statistically significant improvements in the appearance of fine lines and wrinkles, skin texture, pore size, and various dyschromatic conditions within the initial month of use, with continued improvements observed over three months.
- 02 An EGF-containing cream was shown to significantly increase skin moisture and elasticity, alongside a decrease in transepidermal water loss (TEWL) after one week, indicating enhanced skin barrier function.
- 03 One study reported a 73% reduction in melasma over 8 weeks in subjects applying a topical EGF serum twice daily, with no reported side effects.
- 04 An EGF cream reduced inflammatory acne lesions by 33.5% over a six-week period in a study involving 20 subjects.
- 05 However, a systematic review concluded that clinical studies on sh-Oligopeptide-1 for cosmetic purposes lack a strong scientific basis, citing unproven preclinical bioactivity and unknown long-term risks for its use as a cosmetic ingredient.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
This ingredient is highly sensitive to pH, necessitating that the cream's pH is adjusted to between 5.0 and 8.0 before its incorporation. To maintain activity, it must be added as the final step in formulation, at temperatures below 45°C. Strict measures are essential to prevent microbial contamination, which can lead to enzymatic decomposition and loss of activity.
Safety
Safety Profile
S-Mussel Oligopeptide-1 is not currently listed on EWG's Restricted or Unacceptable Lists, and some evaluations suggest it is not likely carcinogenic in humans. However, substantial concerns exist regarding its classification as a 'growth factor.' Overexpression or dysregulation of growth factors, including EGF signaling, is implicated in numerous tumor cells, raising the potential for tumorigenesis. Consequently, any cosmetic application mimicking growth factors should be approached with extreme caution. In vitro tests on mammalian cells have demonstrated positive mutation results linked to cancer. Furthermore, early studies have associated its use with conditions like psoriasis and general skin irritation, potentially due to excessive skin cell proliferation. While authorized as a cosmetic ingredient in various concentrations, its long-term risks remain unknown, and the Cosmetic Ingredient Review (CIR) has not published a specific 'safe as used' assessment for this molecule with a defined maximum concentration.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite some individual studies reporting benefits, S-Mussel Oligopeptide-1's cosmetic efficacy lacks robust scientific consensus, and significant safety concerns, including potential tumorigenesis and unknown long-term risks, render it unsuitable for precision skincare.
Related
Similar Ingredients
Finding similar ingredients…